Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

AZ pays $273m for Ardelyx renal disease drug

Phase II candidate could tackle fluid overload in kidney and heart disorders

- PMLiVE

Takeda pays $60m for vaccine company LigoCyte

Gains first-in-class norovirus candidate and new vaccine platform

- PMLiVE

Massive crackdown on online pharmacies nets fake drugs

Global agencies shut down 18,000 websites and seize medicines worth $10.5m

- PMLiVE

Less than half of UK healthcare professionals use mobile apps for work

Secondary care use higher than in primary care, according to Cegedim Strategic Data study

- PMLiVE

Louise Tamblin returns to Kantar Health as group director

Moves from Strata Research

Shionogi: an expanding commercial focus

PMLiVE’s new emerging companies series starts with a Japanese firm that’s increasing its European footprint

Pharma Comes Out of the Branding Dark Ages

Isn't it high time that the pharma industry takes branding seriously rather than leaving it purely to their portfolio powerhouses?

Janssen adds Astellas JAK inhibitor to its immunology portfolio

Licenses oral rheumatoid arthritis and psoriasis candidate ASP015K

New data backs Pfizer’s Eliquis in atrial fibrillation

Findings bode well for the drug's commercial prospects

- PMLiVE

Clear Channel UK teams up with men’s health charity Movember

The agency will use its digital advertising network to drive awareness of men’s health

- PMLiVE

India revokes Pfizer’s patent on Sutent

Loses patent protection for kidney cancer drug after Cipla and Natco challenge

Icon boosts Asia Pacific and Latin American leadership

Appoints Wei Ming Goh and Dr Dennis Hurley as regional VPs

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links